Linked Data API

Show Search Form

Search Results

1141255
registered interest false more like this
date less than 2019-07-23more like thismore than 2019-07-23
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Non-surgical Cosmetic Procedures: Children more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what legal duties govern the administering of dermal fillers to people under the age of 18 by non-regulated practitioners. more like this
tabling member constituency North Durham more like this
tabling member printed
Mr Kevan Jones more like this
uin 280927 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-07-25more like thismore than 2019-07-25
answer text <p>Currently there are no restrictions that limit the administration of dermal fillers on young people under the age of 18 years old.</p><p>The Department is exploring options to introduce age restrictions on access to cosmetic procedures, bringing them in line with legislation on tattoos, teeth whitening and the use of sunbeds. From May 2020 all dermal fillers, irrespective of their composition and intended use, will be regulated as medical devices under Annex XVI of the Medical Device Regulations (EU 2017/745). The new Regulations will significantly improve the quality and safety of dermal fillers.</p><p>The Government is committed to improving the safety of cosmetic procedures through better training for practitioners, and clear information so that people can make informed decisions about their care. The growth in non-surgical treatments increases the need for consumer protection and we are currently working with stakeholders to strengthen the regulation of cosmetic procedures.</p><p>We urge anyone seeking a cosmetic procedure to take the time to find a reputable, insured and appropriately qualified practitioner who is either subject to statutory regulation or on a voluntary register accredited by the Professional Standards Authority.</p>
answering member constituency Thurrock more like this
answering member printed Jackie Doyle-Price more like this
question first answered
less than 2019-07-25T16:32:36.833Zmore like thismore than 2019-07-25T16:32:36.833Z
answering member
4065
label Biography information for Dame Jackie Doyle-Price more like this
tabling member
1438
label Biography information for Mr Kevan Jones more like this
1141356
registered interest false more like this
date less than 2019-07-23more like thismore than 2019-07-23
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Sapropterin more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment his Department has made of whether Kuvan should be assessed through NICE's highly-specialised technology appraisal. more like this
tabling member constituency North Durham more like this
tabling member printed
Mr Kevan Jones more like this
uin 280943 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-08-06more like thismore than 2019-08-06
answer text <p>Decisions on whether individual medicines are suitable for assessment by the National Institute for Health and Care Excellence (NICE), and whether they meet the criteria for the highly specialised technologies programme, are taken through an established topic selection process.</p><p>The process is overseen by NICE and includes consideration against published criteria by a topic selection panel and engagement with stakeholders. Although NHS England, NHS Improvement and the Department provide input and are part of this panel, the decision-making process is led by NICE. Kuvan for the treatment of phenylketonuria was last considered by the topic selection panel on 15 February 2019.</p><p>In the absence of guidance from NICE, it is for National Health Service organisations and healthcare professionals to make decisions on whether to fund Kuvan on the basis of an assessment of the available evidence. Treatment for patients with phenylketonuria who are not receiving Kuvan or for who Kuvan is not effective includes dietary protein restriction combined with dietary supplements.</p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p>
answering member constituency Bury St Edmunds more like this
answering member printed Jo Churchill more like this
question first answered
less than 2019-08-06T14:36:02.507Zmore like thismore than 2019-08-06T14:36:02.507Z
answering member
4380
label Biography information for Jo Churchill more like this
tabling member
1438
label Biography information for Mr Kevan Jones more like this